STAT
JULY 12, 2024
This week, the late National Hockey League veteran Greg Johnson was diagnosed with chronic traumatic encephalopathy, or CTE. Johnson died by suicide five years ago at the age of 48, having played 14 seasons in the NHL. It’s the latest sign of the prevalence of CTE, a progressive neurodegenerative disease caused by repeated impacts to the head, in professional contact sports.
PharmaVoice
JULY 12, 2024
Patent disputes in the U.S. and abroad have opened the door to new generics ready for launch as soon as September for BMS’ Sprycel.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 12, 2024
Researchers were perplexed when the Food and Drug Administration announced it was investigating whether CAR-T therapy, one of the most effective treatments for blood cancers, could cause lymphoma. This was always a theoretical risk of genetically engineered therapies like CAR-T, but it never materialized in the decades after the technology’s birth.
The Pharmacist
JULY 12, 2024
The Royal Pharmaceutical Society (RPS) has called for evidence on the 'benefits and harms' of a 'facilitated self-selection model' for Pharmacy (P) medicines. Respondents have also been asked to suggest areas where further research is required. The RPS wants to hear from a wide range of pharmacists and pharmacy team members, patient representative bodies, employers, academics, […] The post RPS asks for 'benefits and harms' of P med self-selection appeared first on The Pharmacist.
Speaker: Joe Sharpe and James Carlson
In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.
STAT
JULY 12, 2024
Grave warnings of a crisis in maternal deaths are being slightly eroded by articles suggesting that advocates overreached and that the “crisis” was primarily a function of measurement error. Both sides are partially right, because measuring maternal mortality is uniquely challenging. The question at the heart of identifying a maternal death — “Would this person have died if she hadn’t been pregnant?
pharmaphorum
JULY 12, 2024
A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the digital health sector.The Medicare Physician Fee Schedule (PFS) sets out the method of payment, rates, and codes for healthcare providers participating in Medicare, and is often used by the administration as an instrument to encourage some forms of healthcare intervention.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
BioPharma Dive
JULY 12, 2024
Patent litigation has opened the door to generic copies of Bristol Myers’ Sprycel arriving in the U.S. as soon as September.
STAT
JULY 12, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We hope to catch up on our reading, promenade with the official mascots, and stop by a favorite festival. We may also hold another listening party, where the rotation will likely include this , this , this , this and this.
Drug Channels
JULY 12, 2024
Today’s guest post comes from Gavin Magaha, Senior Director of External Affairs and Policy at Kalderos. Gavin discusses the three key reasons for duplicate discounts between the 340B Drug Pricing Program and the Medicaid Drug Rebate Program. He then explains Oregon’s novel approach to fixing the problem. To learn more, register for Kalderos’ August 21, 2024, webinar: Revolutionizing Government Discount Programs: Why Traditional Methods Fail.
STAT
JULY 12, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we talk about an Illumina competitor’s newest influx of funding, Adam weighs in on Pfizer’s plan for a once-a-day GLP-1 pill, and more.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Pharmacist
JULY 12, 2024
MP Stephen Kinnock will be the government minister with responsibility for pharmacy and general practice, under the title of minister of state for care, it has been announced. Meanwhile, minister of state for health Karin Smyth will take responsibility for medicines regulation, pricing and supply, as well as prescribing. Mr Kinnock, MP for Aberafan Maesteg, […] The post New pharmacy and medicines ministers confirmed appeared first on The Pharmacist.
STAT
JULY 12, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Express Pharma
JULY 12, 2024
Antimicrobials in common practice are used to reduce the duration of illness and the chance of death from infections. They also prevent infections in people who are at high risk, such as patients undergoing surgery and those with weakened immune systems. They are a rare class of medication where the treatment of one patient can potentially affect the outcome of other patients and communities through the transmission of antimicrobial-resistant microbes.
pharmaphorum
JULY 12, 2024
Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate.The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later this year.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Express Pharma
JULY 12, 2024
Live Pharma Coalition, a knowledge-sharing and networking forum is going to organise the LPC 200 Conclave in Chennai on July 21, 2024. The theme of the event is “Digital transformation across pharma: challenges and opportunities”. The event will include a keynote speech, panel discussion, networking session, poster presentation, and exhibition by health tech organisations.
pharmaphorum
JULY 12, 2024
Stay informed about the upcoming EU Artificial Intelligence Act, which will regulate AI use in compliance with EU standards. Learn how this legislation may impact your organisation's AI initiatives.
The Pharmacist
JULY 12, 2024
The government should appoint an independent expert as a ‘medicine supply Tsar’ to tackle medicine shortages, the National Pharmacy Association (NPA) has said. This comes as a recent survey by the NPA and YouGov found that three in 10 patients have struggled to get their medicines in the last year. Some 28% of UK adults […] The post Appoint independent ‘medicine supply Tsar’, NPA tells government appeared first on The Pharmacist.
Pharma Times
JULY 12, 2024
The progressive neurodegenerative disease affects more than 55 million people globally
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
JULY 12, 2024
New UK Health Secretary Wes Streeting orders a 'raw and frank' review of NHS to inform a new 10-year plan to fix it
Pharmaceutical Technology
JULY 12, 2024
The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.
pharmaphorum
JULY 12, 2024
Learn how to effectively connect the clinical, regulatory, and commercial aspects in the development of treatments for rare diseases. Discover strategies and insights for navigating the unique challenges of rare disease drug development.
Pharma Times
JULY 12, 2024
The awards celebrated both medical affairs and nursing professionals in the industry
pharmaphorum
JULY 12, 2024
Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round
Pharma Times
JULY 12, 2024
The serious, rare condition is responsible for up to 7% of all neonatal deaths globally
Pharmaceutical Technology
JULY 12, 2024
Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech for FS001, a potentially first-in-class ADC.
The Pharmacist
JULY 12, 2024
The health secretary has announced an ‘independent investigation’ into the ‘state of the NHS’, to be led by Professor Lord Ara Darzi. The findings of this ‘rapid’ investigation, which will be published in September, will feed into a new 10-year plan ‘to radically reform’ the NHS, for which patients and staff will be consulted ‘soon’. […] The post Lord Darzi tasked to lead investigation into ‘state of the NHS’ appeared first on The Pharmacist.
Outsourcing Pharma
JULY 12, 2024
Blow-fill-seal (BFS) technology has long been a cornerstone of pharmaceutical manufacturing, relied on for packaging sterile liquid medications, including but not limited to ophthalmic and respiratory drug products.
World Pharma News
JULY 12, 2024
A method to screen a wide variety of drug candidates without laborious purification steps could advance the fight against drug-resistant bacteria. Efforts to combat the increasing threat of drug-resistant bacteria are being assisted by a new approach for streamlining the search for antimicrobial drug candidates, pioneered by researchers at Hokkaido University, led by Assistant Professor Kazuki Yamamoto and Professor Satoshi Ichikawa of the Faculty of Pharmaceutical Sciences.
Outsourcing Pharma
JULY 12, 2024
Cellibre, a leader in sustainable biochemical manufacturing, has secured a $2 million grant from the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH).
EMCrit Project
JULY 12, 2024
How do you sedate a critically ill patient for a procedure? EMCrit Project by Scott Weingart, MD FCCM.
The Guardian - Pharmaceutical Industry
JULY 12, 2024
Kate Bingham says ageing population means tackling dementia must be treated as economic imperative A Covid-style effort is needed to ensure NHS patients are first in line for a new wave of dementia drugs, according to the former head of the UK’s vaccine taskforce. Kate Bingham is calling for the immediate recruitment of large numbers of patients to ensure that, as with Covid vaccines, the UK is a leading player in testing and launching drugs.
BioPharma Dive
JULY 12, 2024
Sales data suggest forecasts for the Alzheimer’s drug may be in reach. Elsewhere, Ipsen is licensing an ADC and Novartis is closing a San Diego site.
Outsourcing Pharma
JULY 12, 2024
Thermo Fisherâs cutting-edge ultra-cold facility in Bleiswijk, Netherlands, aims to accelerate advanced therapies development by offering comprehensive cold and ultra-cold services.
Expert insights. Personalized for you.
322 
Let's personalize your content